Last edition
News about " Nilemdo"
Organon to Market Bempedoic Acid Therapy Nilemdo in Key European Markets
Organon, a global healthcare company focused on delivering impactful medicines and solutions for everyday health, has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo (bempedoic acid) across France, Denmark, Iceland, Sweden, Finland, and Norway.
Nilemdo | 11/01/2026 | By Darshana | 156
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members